AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Ozomet-G1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Ozone Pharmaceuticals Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Ozomet-G1 Tablet ER

GlucoDuo ER tablets are antidiabetic medications combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. GlucoDuo ER should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and risks such as kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be limited due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before starting this treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are essential.

Uses of Ozomet-G1 Tablet ER

Managing type 2 diabetes

Major Benefits of Ozomet-G1 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Ozomet-G1 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Ozomet-G1 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ozomet-G1 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Ozomet-G1 Extended-Release Tablet should be administered with a meal.

How Ozomet-G1 Tablet ER works:

Ozomet-G1 Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's response to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Ozomet-G1 Extended-Release tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ozomet-G1 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Ozomet-G1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving may result from excessively high or low blood glucose levels. Refrain from driving if such symptoms manifest.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ozomet-G1 ER tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Ozomet-G1 ER tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Ozomet-G1 Tablet ER to individuals with hepatic impairment. Dosage modification of Ozomet-G1 Tablet ER might be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver disease, Ozomet-G1 Tablet ER therapy typically commences with a reduced initial dose; its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Ozomet-G1 Tablet ER :

Should you forget a dose of Ozomet-G1 Tablet ER, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ozomet-G1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ozomet-G1 Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Ozomet-G1 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Ozomet-G1 Tablet ER and seek immediate medical attention.
Ozomet-G1 ER tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Ozomet-G1 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Ozomet-G1 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Ozomet-G1 ER tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Ozomet-G1 Tablet ER and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Ozomet-G1 Tablet ER
40
MRP 48
17% off